| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Nilotinib | CCLE | pan-cancer | AAC | -0.1 | 0.04 |
| mRNA | pifithrin-alpha | CTRPv2 | pan-cancer | AAC | -0.077 | 0.04 |
| mRNA | RAF265 | CCLE | pan-cancer | AAC | -0.099 | 0.04 |
| mRNA | ELCPK | CTRPv2 | pan-cancer | AAC | -0.1 | 0.04 |
| mRNA | decitabine | CTRPv2 | pan-cancer | AAC | 0.056 | 0.05 |
| mRNA | Bosutinib | GDSC1000 | pan-cancer | AAC | 0.068 | 0.05 |
| mRNA | ruxolitinib | CTRPv2 | pan-cancer | AAC | -0.069 | 0.05 |
| mRNA | BEC | CTRPv2 | pan-cancer | AAC | -0.14 | 0.05 |
| mRNA | BRD-K99006945 | CTRPv2 | pan-cancer | AAC | -0.1 | 0.05 |
| mRNA | 681640 | GDSC1000 | pan-cancer | AAC | 0.075 | 0.05 |